The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
104325077 10432507 7 F 20140408 20160729 20140905 20160803 EXP JP-JNJFOC-20140901546 JANSSEN 56.04 YR A F Y 43.00000 KG 20160803 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
104325077 10432507 1 PS SOVRIAD SIMEPREVIR 1 Oral N 205123 100 MG CAPSULE QD
104325077 10432507 2 SS RIBAVIRIN. RIBAVIRIN 1 Oral Y 0 600 MG QD
104325077 10432507 3 SS RIBAVIRIN. RIBAVIRIN 1 Oral Y 0 400 MG QD
104325077 10432507 4 SS RIBAVIRIN. RIBAVIRIN 1 Oral Y 0 400 MG QD
104325077 10432507 5 SS RIBAVIRIN. RIBAVIRIN 1 Oral Y 0 600 MG QD
104325077 10432507 6 SS RIBAVIRIN. RIBAVIRIN 1 Oral Y 0 400 MG QD
104325077 10432507 7 SS RIBAVIRIN. RIBAVIRIN 1 Oral Y 0 200 MG QD
104325077 10432507 8 SS PEGINTRON PEGINTERFERON ALFA-2B 1 Subcutaneous 0 1.38 UG/KG INJECTION /wk
104325077 10432507 9 C LOCHOL FLUVASTATIN SODIUM 1 Oral 0 30 MG QD
104325077 10432507 10 C EPADEL S ICOSAPENT ETHYL 1 Oral 0 1800 MG QD
104325077 10432507 11 C PROMAC (POLAPREZINC) POLAPREZINC 1 Oral 0 150 MG QD
104325077 10432507 12 C POLAPREZINC POLAPREZINC 1 Oral 0 150 MG UNKNOWN QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
104325077 10432507 1 Chronic hepatitis C
104325077 10432507 2 Chronic hepatitis C
104325077 10432507 3 Chronic hepatitis C
104325077 10432507 4 Chronic hepatitis C
104325077 10432507 5 Chronic hepatitis C
104325077 10432507 6 Chronic hepatitis C
104325077 10432507 7 Chronic hepatitis C
104325077 10432507 8 Chronic hepatitis C
104325077 10432507 9 Chronic hepatitis C
104325077 10432507 10 Prophylaxis
104325077 10432507 11 Prophylaxis
104325077 10432507 12 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
104325077 10432507 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
104325077 10432507 Anaemia
104325077 10432507 Decreased appetite
104325077 10432507 Insomnia
104325077 10432507 Pyrexia
104325077 10432507 Rash pruritic
104325077 10432507 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
104325077 10432507 1 20140408 20140629 0
104325077 10432507 2 20140408 20140511 0
104325077 10432507 3 20140811 20140922 0
104325077 10432507 4 20140512 20140622 0
104325077 10432507 5 20140623 20140713 0
104325077 10432507 6 20140714 20150727 0
104325077 10432507 7 20140728 20140810 0
104325077 10432507 8 20140408 20140915 0
104325077 10432507 9 20140408 20140511 0
104325077 10432507 10 20140408 20140511 0
104325077 10432507 11 20140408 20140511 0
104325077 10432507 12 20140408 20140511 0